Robert califf net worth
Robert M. Food and Drug Administration following a vote by the Senate today.
Who is the head of the fda 2024
Califf was nominated to the post by President Joe Biden in November of His confirmation was hailed by his colleagues in the world of clinical research and academic medicine. His contributions have no doubt improved the lives of millions here and around the world, making Rob uniquely qualified to take on this pivotal role during these unprecedented times.
He went on to earn his medical degree from Duke, and aside from three years of residency in internal medicine at the University of California, San Francisco, Califf spent his entire career as cardiologist, researcher and senior leader at Duke until leaving in to assume the posts of deputy commissioner and later commissioner at the FDA. During his medical training at Duke, Califf was mentored by Dr.
Eugene Stead, Jr. As the founding director of the DCRI, Califf oversaw and in many cases personally led numerous pivotal trials in cardiology and other medical specialties. Despite the demands of his career in clinical research, throughout his decades at Duke, Califf continued to see patients as a working cardiologist. He distinguished himself as a teacher and mentor, helping to shape a new generation of physicians and clinical researchers.
After stepping down from his leadership post at the DCRI in , Califf served as vice chancellor for clinical and translational research at Duke before moving to the FDA. Shortly afterward, Obama nominated him as commissioner and the Senate confirmed him in early In particular, this included developing a framework for incorporating new sources of data, including information gathered from sources such as electronic health records and administrative databases.
After leaving the FDA in early , Califf returned briefly to Duke to create and lead Duke Forge, a university center for health data science, before transitioning in to a leadership role as senior adviser at Verily Life Sciences, a Google-affiliated company focused on health data.